loader from loading.io

In the News.. Oral Meds for T1D, Dexcom API News, Closed Loop and Teens, Olympics and more!

Diabetes Connections | Type 1 Diabetes

Release Date: 07/23/2021

The FDA pulled it, but the diabetes community wouldn’t let it go. How the T1D1 app made a comeback show art The FDA pulled it, but the diabetes community wouldn’t let it go. How the T1D1 app made a comeback

Diabetes Connections | Type 1 Diabetes

Two years ago the FDA pulled down just about every insulin calculator app. A lot of them just disappeared, rather than seek official approval, but one of them – created by a teenager with type 1 – is back. I’m talking with Drew and Mike Mendelow about a free and ad-free insulin-dose calculator app. They share what it was like to navigate the FDA process, how they go international help, and what’s next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to ...

info_outline
In the News... Universal T1D screening studied, Dexcom new product, Afrezza prescribing guidelines update, and more! show art In the News... Universal T1D screening studied, Dexcom new product, Afrezza prescribing guidelines update, and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and the show is...

info_outline
Chris Dunn got screened for her kids, turns out SHE has type 1 diabetes show art Chris Dunn got screened for her kids, turns out SHE has type 1 diabetes

Diabetes Connections | Type 1 Diabetes

Imagine getting your kids screened for T1D and agreeing to do it yourself, just to set a good example, and then your test is the one that comes back with type 1! That’s exactly what happened to Chris Dunn. She was positive for all of the autoantibodies and has since been treated with Tzield, the medication shown to delay the onset. We’re talking to her about all of that, what the treatment is actually like, how she’s doing since and what her family thinks of the whole thing. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health...

info_outline
In the News... New islets study, Tzield for babies, MiniMed Go approved, Civica insulin launched, and more! show art In the News... New islets study, Tzield for babies, MiniMed Go approved, Civica insulin launched, and more!

Diabetes Connections | Type 1 Diabetes

It's In the News... the top diabetes stories and headlines happening now! Top stories this week include: new islet encapsulation trial, FDA agrees to review Tzield for babies and approves the MiniMed Go, Civica releases it's version of Lantus, Eversense launches with a pump partner, scholarship for college students with diabetes and more! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up...

info_outline
GLP-1s for Type 1 Diabetes: Are We  There Yet? With Dr. Cecilia Low Wang show art GLP-1s for Type 1 Diabetes: Are We There Yet? With Dr. Cecilia Low Wang

Diabetes Connections | Type 1 Diabetes

One of the sure-thing top stories of 2026 will be GLP1s, but will we see more studies and even approval for treating type 1 with these medications? We're talking about Ozempic, Mounjaro and the next versions like Retatrutide - that are just around the corner. I’m talking to  Dr. Cecelia Lo Wong, a diabetologist at the University of Colorado whose been on the front lines of this conversation for years,  including serving on FDA advisory committees. This is a wide ranging interview - we also talk about the growing needs of older adults with type 1 diabetes, how kidney and...

info_outline
In the News PLUS our 2026 Predictions show art In the News PLUS our 2026 Predictions

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week we're also making predictions for diabetes news in 2026! This week's top stories: statins and type 2, big results from Lilly's newest weight loss drug, MiniMed IPO, Tandem app update, and more! Predicitons include thouhts around: continuous ketone monitoring, noninvasive gucose moniotring, inhalable insulin for kids, GLP1 backlash, A1 slop in diabetes mom groups and more! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners -...

info_outline
Looking back on 2025: Hype, hope and what really matters, with Neil Greathouse show art Looking back on 2025: Hype, hope and what really matters, with Neil Greathouse

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections, a conversation about what really matters in diabetes. We’re talking about the top stories of 2025, the hype that didn’t happen, some trends for 2026, what community can accomplish, and what LeBron James has to do with all of this. We also get personal – because I’m being interviewed by the wonderful Neil Greathouse, host of Your Best T1D life, and so much more. This episode contains a replay of This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community...

info_outline
Do We Need an At-Home A1C Test in the  Age of CGM? Orange Biomed Says Yes show art Do We Need an At-Home A1C Test in the Age of CGM? Orange Biomed Says Yes

Diabetes Connections | Type 1 Diabetes

Making the case for a better at home A1C test. Orange Biomed is developing a compact, one-drop, at-home A1C testing device they say could make frequent A1C checks easier and more accessible than ever. They’re passionate about closing the gap for people who struggle to get to clinics regularly… and the research they share is compelling: four A1C tests a year can lead to a nearly 4% reduction in A1C levels. We’ll talk about why more frequent A1C monitoring matters—even in the era of continuous glucose monitoring—how their new device works, and what early clinical trial results look...

info_outline
She Turned Her Glucose Data Into Art. Could it Change How People See Diabetes? show art She Turned Her Glucose Data Into Art. Could it Change How People See Diabetes?

Diabetes Connections | Type 1 Diabetes

What if your glucose graph became a tangible piece of art? Something you could pring out and put on your water bottle or the back of your laptop. I’ve seen this in person and it makes a big impact on people. This week I’m talking to Krista Shenaman about making this type of art, her journey with type 2 – and it’s been a journey, she took a “record breaking” 28 day walk after her diagnosis.. – why she thinks its helpful to look at data in a new way and more.    Full disclosure: We recorded this interview way back in 2024! Technical issues and thought it was lost,...

info_outline
Dexcom’s 15-Day G7 Is Here: What’s Changing, What’s Next, and What You Need to Know show art Dexcom’s 15-Day G7 Is Here: What’s Changing, What’s Next, and What You Need to Know

Diabetes Connections | Type 1 Diabetes

It’s been a big month for announcements from Dexcom! What does that mean for you?  From the commercial launch of the 15 day sensor and a smart basal feature to the announced phase out of the G6 and more, I’m talking with Jessica Castle, vice president of Global Medical Affairs at Dexcom. We’re covering all of this news and she’s answering your questions. More about More about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to  Learn more about ...

info_outline
 
More Episodes
It's "In the News..." the only LIVE diabetes newscast! Our top stories this week:  Oral meds to prevent T1D move ahead, racial disparity in peds CGM use, what that Dexcom API news means, a new study with teens and Control IQ and a summer olympian talks about her recent T1D diagnosis.
Join Stacey live on Facebook each Wednesday at 4:30pm EDT!

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

Episode transcript below:

 

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more when you have the time.

XX

Our top story.. A new oral drug to prevent type 1 is moving along in trials. Right now it’s called IMT-002 – and put very simply - it’s meant to block a genetic trait that increases the risk for the disease and is seen in a majority of patients.

It’s a new way to think about treating type 1 – phase two studies could start next year. It’s thought that this could help with other auto-immune diseases as well.. the next condition these researchers want to tackle is celiac.

https://www.biospace.com/article/releases/im-therapeutics-reports-positive-results-in-safety-tolerability-and-mechanism-of-action-of-phase-1b-trial-of-lead-drug-imt-002-in-type-1-diabetes/

XX

Could the global rise in diabetes have an environmental component? In an Advances in Pharmacology article, researchers say routine exposure to chemicals that disrupt our endocrine systems play a role in triggering diabetes.

These researchers say "We often attribute patient's disease risk to individual choices, and we don't necessarily think about how systems and environments play into disease risk," They go on to say so-called lifestyle factors like exercise and diet fail to fully account for "the dramatic rise and spread" of diabetes.

https://www.ehn.org/environmental-factors-of-diabetes-2653768475/how-endocrine-disruptors-contribute-to-diabetes

XX

A new study shows Black children less likely to start or continue with a CGM after a type 1 diabetes diagnosis. These researchers at Children’s Hospital of Philadelphia or CHOP as it’s commonly known, show that a racial-ethnic disparity in CGM use begins within the first of year after diagnosis.

White children were more than two and a half times more likely to start CGM compared with Black children and twice as likely to start CGM compared with Hispanic children. There was a disparity even when broken down by types of insurance – commercial or government.

These researchers say social determinants including structural racism, are likely playing a role in disparities in care and outcomes

https://www.healio.com/news/endocrinology/20210719/black-children-less-likely-to-start-continue-cgm-after-type-1-diabetes-diagnosis

XX

Very large survey of women shows that half of those with type 1 or type 2 diabetes are not getting pre-pregnancy counseling. This study included more than 100-thousand women. Right now guidelines from many groups including the CDC and American Diabetes Association recommend providers offer women with diabetes health counseling before pregnancy to cut down on the increased maternal and infant risk associated with both conditions. These researchers hope to develop better tools for women & their doctors.

https://publichealth.berkeley.edu/news-media/research-highlights/women-with-diabetes-and-hypertension-dont-receive-pre-pregnancy-counseling/

XX

Big increase for time in range when kids use hybrid closed loop systems. We’ve heard about a lot of improvement, but in this study, the percentage of kids and teens with t1d spending at least 70% time in range… more than doubled after 3 months of using Tandem’s Control IQ system. This was a study of about 200 kids, median age was 14, and it was a real world study – where the kids went about their lives, not in a clinical setting, and the researchers pulled the data electronically.

Interestingly, sleep mode use increased through 6 months, while the exercise mode was used less over time.

Kids with an A1C over 9 saw the most improvement. Those with an A1C under 7 didn’t see much of a change.

https://www.healio.com/news/endocrinology/20210714/more-youths-with-type-1-diabetes-meet-timeinrange-goal-with-hybrid-closedloop-system

XX

Dexcom gets FDA clearance for real time APIs.. what does that mean? Third party companies like Fitbit or Sugarmate which have long integrated Dexcom data have been doing so on a bit of a delay. Now they can do so in real time.

API stands for Application Programming Interface, which is a software intermediary that allows two applications to talk to each other.

Dexcom’s Partner Web APIs will allow users to view all of their diabetes care data in one place to enable in-the-moment feedback and adjustments, the company said in the announcement.

 

https://www.mobihealthnews.com/news/dexcom-gets-fda-nod-its-new-api-integration

 

XX

Cool new exhibit at Banting House – recent guests of the podcast and museum celebrating the birthplace of insulin.

They’re set to open up again this week – the first time since March 2020 – and there’s a new computer generated exhibit. It does work outside.. In the square where Dr. Banting’s statue stands. Giving visitors a virtual glimpse at the life and work of the man credited for the discovery of insulin. If you haven’t visited – it’s in Canada – or seen the museum, I highly recommend a spin around the website, we’ll link it up.

XX

Summer Olympics are kicking off and by now you’ve probably heard that American trampoline gymnast Charlotte Drury was just recently diagnosed. She found out she had type 1 weeks before the 2021 Olympic qualifying trials, she revealed on Instagram last week. she and her coach pressed on and she basically got back into things within three weeks. She posted this photo of herself wearing the Dexcom. Drury is the first American woman to win a gold medal in trampoline at a World Cup

That’s Diabetes Connections – In the News.  If you like it, share it. And feel free to send me your news tips. Stacey @ diabetes dash connections dot com.

Please join me wherever you get podcasts for our next episode -Tuesday –  I’ll share my conversation with Gold Medal Olympian Gary Hall Jr – when he was diagnosed in 1999 he was told to give up swimming. He didn’t and he talks about why.. and how he overcame what was conventional wisdom for athletes at the time. This week’s show is the story of Jack Tierney, diagnosed in 1959 with type 1 he’s 81 and he says he’s never felt better.

Thanks and I’ll see you soon